The prognostic and predictive significance of cytokeratin 5/6 and epidermal growth factor receptor in metastatic triple-negative breast cancer treated with maintenance capecitabine

BACKGROUND: Capecitabine is the most widely used agent for maintenance chemotherapy in patients with metastatic triple-negative breast cancer (mTNBC). However, there are no biomarkers for identifying mTNBC patients who could benefit from capecitabine maintenance. METHODS: The prognostic roles of cyt...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yiping, Li, Kai, Zhang, Jieling, Wang, Lu, Sheng, Lili, Yan, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798347/
https://www.ncbi.nlm.nih.gov/pubmed/35116447
http://dx.doi.org/10.21037/tcr-20-1760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798347/
https://www.ncbi.nlm.nih.gov/pubmed/35116447
http://dx.doi.org/10.21037/tcr-20-1760

Ejemplares similares